Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
Chr t(14;16)
Associations
(11)
News
Trials
B | Sensitive
C2 | Sensitive
C3 | Sensitive
B | Resistant
C2 | Resistant
C3 | Resistant
Show legend
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Interleukins
Proteasome Inhibitors
Cancel
Multiple Myeloma
Leukemia
DVD
B
Chr t(14;16)
|
Multiple Myeloma
|
DVD
Isa-KRd
C3
Chr t(14;16)
|
Multiple Myeloma
|
Isa-KRd
Proteasome inhibitor + Immunomodulator
C3
Chr t(14;16)
|
Multiple Myeloma
|
Proteasome inhibitor + Immunomodulator
daratumumab
B
Chr t(14;16)
|
Multiple Myeloma
|
daratumumab
lenalidomide + isatuximab-irfc
B
Chr t(14;16)
|
Multiple Myeloma
|
lenalidomide + isatuximab-irfc
elranatamab-bcmm
C3
Chr t(14;16)
|
Multiple Myeloma
|
elranatamab-bcmm
lenalidomide + ixazomib
C3
Chr t(14;16)
|
Multiple Myeloma
|
lenalidomide + ixazomib
ixazomib
C2
Chr t(14;16)
|
Multiple Myeloma
|
ixazomib
lenalidomide
C3
Chr t(14;16)
|
Multiple Myeloma
|
lenalidomide
C3
Chr t(14;16)
|
Leukemia
|
lenalidomide
lenalidomide + elotuzumab
C3
Chr t(14;16)
|
Multiple Myeloma
|
lenalidomide + elotuzumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
